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Background: Reciprocal interactions between lung mesenchymal and epithelial cells play essential roles in lung
organogenesis and homeostasis. Although the molecular markers and related animal models that target lung
epithelial cells are relatively well studied, molecular markers of lung mesenchymal cells and the genetic tools to
target and/or manipulate gene expression in a lung mesenchyme-specific manner are not available, which becomes
a critical barrier to the study of lung mesenchymal biology and the related pulmonary diseases.
Results: We have identified a mouse Tbx4 gene enhancer that contains conserved DNA sequences across many
vertebrate species with lung or lung-like gas exchange organ. We then generate a mouse line to express rtTA/LacZ
under the control of the Tbx4 lung enhancer, and therefore a Tet-On inducible transgenic system to target lung
mesenchymal cells at different developmental stages. By combining a Tbx4-rtTA driven Tet-On inducible Cre
expression mouse line with a Cre reporter mouse line, the spatial-temporal patterns of Tbx4 lung enhancer targeted
lung mesenchymal cells were defined. Pulmonary endothelial cells and vascular smooth muscle cells were targeted by
the Tbx4-rtTA driver line prior to E11.5 and E15.5, respectively, while other subtypes of lung mesenchymal cells including
airway smooth muscle cells, fibroblasts, pericytes could be targeted during the entire developmental stage.
Conclusions: Developmental lung mesenchymal cells can be specifically marked by Tbx4 lung enhancer activity.
With our newly created Tbx4 lung enhancer-driven Tet-On inducible system, lung mesenchymal cells can be
specifically and differentially targeted in vivo for the first time by controlling the doxycycline induction time
window. This novel system provides a unique tool to study lung mesenchymal cell lineages and gene functions in
lung mesenchymal development, injury repair, and regeneration in mice.
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The lung is originally developed from ventral foregut
endoderm and surrounding splanchnic mesoderm [1,2].
Reciprocal interactions between lung mesenchymal and
epithelial cells play essential roles in lung organogenesis
and homeostasis. In fetal mice, lung epithelial cells are ini-
tially specified by Nkx2.1 expression around embryonic
day (E) 9.5, followed by lung bud growth, airway branch-
ing morphogenesis, and terminal saccular formation [3].* Correspondence: wshi@chla.usc.edu
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stated.During this developmental process, a wide variety of lung-
specific epithelial cells are differentiated from their epithe-
lial progenitor cells. The molecular markers and related
animal models to target these epithelial cells are relatively
well studied. However, developmental lung mesenchymal
progenitor cells and their differentiation are poorly under-
stood. Many unsolved issues of lung mesenchymal biology,
such as whether mesenchymal cells in the developing lung
are different from those in other organs and whether lung
smooth muscle cells in airways and vasculature are de-
rived from the same lung mesenchymal progenitors, re-
main critical questions in the field of lung research.
Furthermore, no animal model is available to specifically
target lung mesenchymal cells in order to manipulate gene
expression in these cells [4]. Therefore, novel molecularLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Zhang et al. BMC Biology 2013, 11:111 Page 2 of 12
http://www.biomedcentral.com/1741-7007/11/111approaches and genetic tools to specifically target lung
mesenchyme from the beginning of lung formation are ur-
gently needed.
Tbx4 is a member of the T-box transcription factor
family, which play important roles during embryonic de-
velopment through modulating gene expression [5].
Endogenous Tbx4 gene expression is detected in many
mesoderm-derived tissues including lung mesenchyme
[6], but is not specific for lung [7]. However, Menke et al.
recently reported that Tbx4 expression in different tissues
is controlled by a dispersed group of enhancers at different
loci within the Tbx4 genomic structure. One of these is lo-
cated in the third intron and is conserved among several
mammalian species [8]. A 5.5 kb DNA segment from this
region is able to drive transgenic reporter expression in
the developing lung and trachea at E12.5. However, de-
tailed characteristics of this lung enhancer, including the
spatial-temporal pattern of the enhancer activity at differ-
ent developmental or post-developmental stages, are not
known. By taking advantage of this potential lung-specific
enhancer of the mouse Tbx4 gene expression, we have
generated a new Tbx4 lung enhancer driven-reverse tetra-
cycline transactivator (Tbx4-rtTA) transgenic mouse line.
We then developed a lung-specific Tet-On inducible
transgenic mouse model by crossing Tbx4-rtTA mice with
TetO-Cre mice. Using loxP-mTomato-STOP-loxP-mGFP
(mT-mG) reporter mice, we were thus able to identify and
define the spatial-temporal pattern of Tbx4-rtTA-targeted
lung mesenchymal progenitors and their derived cells dur-
ing different stages of lung development and adulthood.
Thus, our new lung mesenchymal-specific Tet-On indu-
cible genetic system provides a valuable tool for the study
of lung mesenchymal cells under both physiological and
pathophysiological conditions.Results
The lung enhancer of the mouse Tbx4 gene contains
genomic DNA sequence elements that are highly
conserved across species that have lungs or lung-like gas
exchange organs
In order to understand the role of the 5.5 DNA fragment in
mouse Tbx4 intron 3 that has the potential to drive gene
expression in mouse lung [8], the evolutionary conservation
of this region was analyzed across 60 different vertebrate
species using the BLAT program available through Univer-
sity of California Santa Cruz (UCSC) Genome Bioinfor-
matics [9]. Interestingly, several fragments of the DNA
sequences exhibited high similarity in 40 placental mam-
mals (Figure 1A). In particular, a DNA fragment of about
500 bp in the middle of the region of interest appeared
highly conserved in most vertebrate species that have a
lung-like respiratory organ. For instance, coelacanth, an an-
cient kind of fish close to lungfishes and tetrapods, not onlyhas a fat-filled single-lobed lung [10], but also a sequence
homologous to this mouse Tbx4 region. In contrast, no
such DNA sequence similarity was found in other fishes
that do not develop lung-like structures (Figure 1B). This
suggests that this Tbx4 DNA segment may be an early
evolutionary adaptation that is important for successful
morphogenesis of gas exchange organs for air breathing.
Generation of a Tbx4-lung enhancer driven Tet-On system
that specifically targets lung mesenchyme
Tbx4-rtTA transgenic mice were generated using a DNA
vector as illustrated in Figure 2A, in which simultaneous
expression of a reverse tetracycline transactivator (rtTA)
and a lacZ (rtTA-IRES-LacZ) was controlled by the 5.5 kb
mouse Tbx4 lung enhancer. Two founder lines of mice
were positive for Tbx4-rtTA transgene integration as
detected by both genomic PCR and Southern blot
(Figure 2B-C). Active expression of the transgene rtTA-
IRES-LacZ driven by the Tbx4 lung enhancer was easily
verified by detecting nuclear LacZ activity with X-gal stain-
ing (Figure 2D). In order to further trace and characterize
the cell types with Tbx4-driven rtTA expression, the mice
were then crossed to TetO-Cre mice to make a Tet-On in-
ducible Cre expression system [13], in which Cre expres-
sion was induced in rtTA expressing cells whenever
doxycycline (Dox) is added. By further crossing to a mT-
mG (loxP-mTomato-STOP-loxP-mGFP) fluorescent pro-
tein reporter mouse line [14], cells with Cre expression can
be easily detected by mGFP expression as a result of Cre-
mediated floxed-mTomato deletion, while Cre-negative
cells still express mTomato. As shown in Figure 2E, Dox
induction (E6.5 to E13.5) resulted in mGFP expression only
in embryonic lung of the triple transgenic mice (Tbx4-
rtTA/TetO-Cre/mT-mG) by gross view. In contrast, control
mice without Tbx4-rtTA transgene (TetO-Cre/mT-mG)
did not express mGFP, confirming the specificity of the
Tbx4-rtTA transgene-mediated Cre reporter system. More-
over, sagittal sections of the E10.5 triple transgenic embryo
showed that Cre-mediated mGFP expression was restricted
to the lung buds and not detected in other organs. Within
the lung bud, mGFP expression was restricted to mesen-
chymal cells surrounding the epithelial buds, including
the outer layer of mesothelial progenitor cells of the vis-
ceral pleural membrane (Figure 2F). This lung/tracheal
mesenchyme-specific pattern of Cre induction by the
Tbx4-rtTA transgene persisted to the end of gestation,
since no mGFP was detected in organs other than the
lung and trachea of the triple transgenic mice with con-
tinuous Dox induction from E6.5 to E18.5 (Figure 2G).
Dynamic pattern of Tbx4 lung enhancer-driven lung
mesenchymal cell targeting during and after development
As mentioned above, mouse lung development starts
around E9.5. Based on the morphological features, lung
Figure 1 Analysis of the 5.5 kb genomic DNA sequences of the potential mouse Tbx4 lung enhancer. (A) Placental mammal basewise
conservation scores determined by phyloP program [11]. Positive scores are assigned to the sites with conserved DNA sequences among the
studied vertebrate species, which include mouse, rat, kangaroo rat, naked mole rat, guinea pig, squirrel, rabbit, pika, human, chimp, gorilla,
orangutan, gibbon, rhesus, baboon, marmoset, squirrel monkey, tarsier, mouse lemur, bushbaby, treeshrew, pig, alpaca, dolphin, sheep, cow, cat,
dog, panda, horse, microbat, megabat, hedgehog, shrew, elephant, rock hyrax, tenrecs, manatee, armadillo, sloth, opossum, Tasmanian devil,
wallaby, platypus, turkey, chicken, zebra finch, budgerigar, lizard, painted turtle, xenopus tropicalis, coelacanth, tetraodon, fugu, nile tilapia,
stickleback, medaka, Atlantic cod, zebrafish, lamprey. (B) The related sequence alignments of the above vertebrates to mouse Tbx4 genomic DNA
sequence by Multiz program [12]. Most sequence alignments were omitted due to limited space. Identical nucleotide sequences are indicated by
vertical black bar.
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lar (E10.5-E16.5), canacular (E16.5-E17.5), saccular (E17.5-
P5), and alveolar (P5-P30) stages. Lung mesenchymal
progenitor cells proliferate and differentiate into different
types of cells in concert with lung epithelial growth.
Therefore, Tbx4-rtTA targeted lung mesenchymal cells
may undergo developmental changes at different lung de-
velopmental stages as well as in post-development of the
adult lung. Thus, the Tbx4-rtTA mediated Tet-On Cre in-
ducible triple transgenic reporter mice were examined
when Dox induction was initiated at different gestation
time windows and postnatal ages. As shown in Figure 3A,
Dox administration before lung formation (E8.5) was not
able to induce Cre expression in any tissues including
lung, as illustrated by negative mGFP expression in E13.5
embryos, while Dox administration from E8.5 to E9.5
started to induce Cre expression in some lung mesenchy-
mal cells. During prenatal and postnatal lung development,
the Tbx4-rtTA driven Tet-On system was very efficient in
inducing Cre expression in lung mesenchyme (Figure 3B).
For example, about 91% of cytokeratin-negative cells inperipheral lung saccular structure at E18.5 had inducible
Cre expression when Dox was given to the triple trans-
genic mice (Tbx4-rtTA/TetO-Cre/mT-mG) from E6.5 to
E18.5. Although Cre induction in adult lung was still de-
tected in many lung mesenchymal cells including airway
smooth muscle cells, the efficiency of Cre induction was
reduced compared to that seen during lung development,
as shown by reduction in the proportion of mGFP-positive
cells (Figure 3).
Differential targeting of smooth muscle cells by the Tbx4
lung enhancer in developing lung
In the triple transgenic (Tbx4-rtTA/TetO-Cre/mT-mG)
mouse system described above, mGFP expression persists
within cells once Cre-mediated floxed-mTomato deletion
has occurred. Thus, mGFP-positive cells do not necessarily
represent an active status of the Tbx4 lung enhancer-
driven rtTA/LacZ expression. Since the TetO-Cre trans-
gene is ubiquitously expressed, the Tet-On induction is
dependent upon Tbx4-rtTA/LacZ transgenic expression.
Therefore, by comparing the expression pattern of mGFP
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time windows, cells that previously expressed Cre in early
lung development could be distinguished from the cells
that were still actively expressing Cre. Hence, the activity
of Tbx4 lung enhancer-mediated targeting to a variety of
differentiated lung mesenchymal cells could be analyzed.
With continuous induction of Dox during the entire
period of fetal lung development (E6.5 to E18.5), no mGFP-
positive epithelial cells were detected as demonstrated byFigure 2 Generation of an embryonic/fetal lung-specific Tbx4-rtTA tra
construct. The position of the DNA probe for Southern blot is indicated. (B
(C) Verification of transgenic lines by Southern blot. Genomic DNA was dig
(D) Expression of rtTA-IRES-LacZ transgene in E13.5 lung was verified by X-
detected in the lung of the triple transgenic mice (Tbx4-rtTA/TetO-Cre/mT-
in which floxed-mTomato expression (red) was not affected. Dox induction
visualized under a fluorescence dissecting microscope. (F) Sagittal frozen se
from E6.5 to E10.5. Right panel shows the lung bud structure under high mag
sections from E18.5 triple transgenic mice (Tbx4-rtTA/TetO-Cre/mT-mG), in wh
lung and tracheal mesenchyme, but not in other tissues. Dox, doxycycline; E,GFP and cytokeratin co-immunostaining (Figure 4A).
Furthermore, not all mGFP-positive cells were LacZ
positive, while LacZ-positive cells were all mGFP-positive
(Figure 4A), suggesting that some of the targeted lung
mesenchymal cells lost the Tbx4 lung enhancer activity
during lung development. In order to understand whether
loss of the Tbx4 lung enhancer activity is related to
changes in differentiation status of lung mesenchymal
cells, we first looked at lung smooth muscle cells bynsgenic mouse line. (A) Schematic diagram of transgenic DNA
) Screen of transgenic founder lines by genomic DNA PCR.
ested by XhoI and SalI prior to separation by gel electrophoresis.
gal staining (blue). (E) Cre-mediated mGFP expression (green) was
mG), but not in the double transgenic control mice (TetO-Cre/mT-mG),
was started from E6.5, and E13.5 mouse embryos were isolated and
ction of E10.5 embryo of the triple transgenic mice with Dox induction
nification. (G) Fluorescence microscopic examination of tissue frozen
ich Dox induction was initiated from E6.5. mGFP was detected only in
embryonic day.
Figure 3 Dynamic expression profile of Tbx4-rtTA-mediated Tet-On targeting system shown by the triple transgenic reporter
(Tbx4-rtTA/TetO-Cre/mT-mG). (A) Tbx4-rtTA-mediated Tet-On system targeted lung mesenchyme was initiated immediately after lung
morphogenesis at E9.5. Dox induction was given at different time windows of early gestation, and the sagittal frozen sections of E13.5 embryos
were used to detect mGFP (green) and mTomato (red) expression. Nuclei were counterstained with DAPI (blue). Lung tissue (L) was marked on
the left side of the dotted line, and vertebrae (V) were located on the right side. (B) Efficiencies of cell targeting by the Tbx4-rtTA mediated
Tet-On inducible system at different prenatal and postnatal stages. The time windows of Dox induction are indicated above each panel, and the
ages of the examined lung specimens are specified inside each panel. DAPI, 4',6-diamidino-2-phenylindole; Dox, doxycycline; E, embryonic day.
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and mGFP or SMA and LacZ. As shown in Figure 4B,
Dox induction from E6.5 to E18.5 resulted in mGFP ex-
pression in both airway and vascular smooth muscle cells,
suggesting that the smooth muscle cells of these structures
were originally targeted by Tbx4 lung enhancer during
fetal lung development. However, LacZ expression was
only detected in smooth muscle cells of the E18.5 airways,
but not in the vascular smooth muscle cells, indicating
that the Tbx4 lung enhancer was not active in differenti-
ated vascular smooth muscle cells at late gestation (E18.5).
We then further determined the developmental time win-
dows during which the Tbx4-lung enhancer was turned
off in vascular smooth muscle cells. In E15.5 lung with
Dox induction from E11.5, co-expression of mGFP and
LacZ was seen in smooth muscle cells of both airway and
vasculature; however, the intensity of lacZ staining in vas-
cular smooth muscle cells was significantly reduced com-
pared to that seen in airway smooth muscle cells. Incontrast, in E18.5 lung with Dox induction from E15.5, co-
expression of mGFP and LacZ was detected in airway
smooth muscle cells only, with no expression of mGFP
and LacZ in the vascular smooth muscle cells, suggesting
that the Tbx4-lung enhancer was not active in differenti-
ated vasculature smooth muscle cells after E15.5. There-
fore, the Tbx4 lung enhancer is able to target smooth
muscle cells of both airway and vascular lineages prior to
E15.5, but mainly airway smooth muscle cells at later times
in gestation.
Differential targeting of pulmonary endothelial cells by
the Tbx4 lung enhancer in developing lung
Endothelial cells in the pulmonary vasculature were also
mGFP-positive in the triple transgenic lung specimens
with Dox induction from E6.5 to E18.5 (Figure 5A). How-
ever, these mGFP-positive endothelial cells were LacZ-
negative at E18.5, suggesting that the Tbx4 lung enhancer
might target endothelial progenitor cells during early lung
Figure 4 Differential targeting of lung smooth muscle cells by the Tbx4 lung enhancer at different gestational ages. (A) Tbx4 lung
enhancer-mediated Tet-On induction activity was only detected in cytokeratin (Cyt)-negative cells, shown by GFP and Cyt co-immunostaining. In
addition, not all GFP-positive cells were lacZ-positive, shown by GFP and LacZ co-immunostaining. The lung specimens were taken from the
E18.5 triple transgenic fetuses with Dox induction time windows indicated above the panels. (B-D) Co-immunostaining of GFP, LacZ and SMA for
the lungs of E18.5 (B), E15.5 (C), and E18.5 (D) triple transgenic fetuses with different Dox inductions indicated above the panels. a: airway;
v: vasculature. Dox, doxycycline; SMA, α-smooth muscle actin.
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ferent developmental stages in combination with different
Dox induction time windows. In E15.5 triple transgenic
lung with Dox induction from E6.5 to 10.5, endothelial
cells, detected by platelet endothelial cell adhesion mol-
ecule (PECAM-1) immunostaining, were positive for
mGFP, but not for LacZ (Figure 5B). Moreover, in E15.5
triple transgenic lung with Dox induction from E11.5 to
15.5, all PECAM-1-positive cells were negative for both
mGFP and LacZ (Figure 5C). These data indicate that pul-
monary endothelial cells may be derived from lung mesen-
chymal progenitors at an early gestation stage prior to
E11.5 and that the Tbx4 lung enhancer-mediated Tet-On
system is able to target these progenitor cells if Dox induc-
tion is given before E11.5.
Other lung cell lineages targeted by the Tbx4 lung
enhancer during lung development
In addition to smooth muscle cells and endothelial cells,
we also looked at other differentiated lung mesenchymal
cells targeted by the Tbx4 lung enhancer. Lung myofi-
broblasts and lipofibroblasts in the alveolar septal struc-
tures, which can be identified by SMA and adipophilin
(ADRP) immunostaining, respectively [15,16], are im-
portant for lung alveolar formation and maintenance. In
the primary alveolar sacs of E18.5 triple transgenic mice
with Dox induction from either E6.5 to E18.5, or E15.5
to E18.5, both myofibroblasts and lipofibroblasts were all
GFP-positive (Figure 6), suggesting that fetal Tbx4-rtTA
expressing cells can be the progenitors for both of thesespecialized subpopulations of lung fibroblasts throughout
the entire prenatal stage. Moreover, Tbx4 lung enhancer-
targeting was also detected in potential lung pericytes by
co-immunostaining of GFP and NG2, one of the markers
for pericytes (Figure 7A). In E15.5 lungs of the triple trans-
genic mice with Dox induction either from E6.5 to 10.5 or
11.5 to E15.5, NG2-positive staining was detected in both
vascular smooth muscle cells and dispersed individual mes-
enchymal cells, which were all GFP-positive (Figure 7B-C).
This suggests that the NG2-positive cells are derived from
the Tbx4 lung enhancer targeted cells. In contrast, pulmon-
ary neuroendocrine cells, as identified by calcitonin gene-
related peptide (CGRP) expression, were not targeted by
the Tbx4-lung enhancer driver, as determined by negative
GFP staining in the CGRP-positive cells of the triple trans-
genic mouse lung [see Additional file 1].
Discussion
Mesenchymal cells in a variety of tissues are mainly de-
rived from mesoderm during organogenesis. They play
important roles in guiding organogenesis, generating the
tissue-specific mesenchymal progenitor/stem cells needed
for homeostasis in developed organs, and can differentiate
into fibroblasts, smooth muscle cells, chondrocytes and
other types of mesenchymal cells that support specific tis-
sue functions. However, genetic markers specifically for
mesenchymal cells in individual visceral tissue, including
lung mesenchyme, have not been well defined. For ex-
ample, in Dermo1-Cre knockin mice, Dermo1 promoter
drives Cre expression in many mesoderm-derived tissues
Figure 5 Differential targeting of lung vascular endothelial cells by the Tbx4 lung enhancer at different gestational ages. (A) In E18.5
lung of the triple transgenic mice with Dox induction from E6.5, PECAM-1-positive endothelial cells were GFP positive, but LacZ negative. (B-C) in
the E15.5 lung of the triple transgenic mice with different Dox induction time windows as indicated above the panel, vascular endothelial cells
were GFP-positive if Dox induction was given prior to E10.5 (B), but LacZ expression was already negative. Consistently, Dox induction from E11.5
to E15.5 was not able to target vascular endothelial cells, shown by double negative staining for GFP and LacZ (C). V: vasculature. Dox,
doxycycline; E, embryonic day; PECAM-1, platelet endothelial cell adhesion molecule.
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walls [17-19]. Similarly, although endogenous Tbx4 ex-
pression was detected in the mesenchyme of lung and tra-
chea around E9.25, a few hours after the specification of
the lung and trachea primordia by Nxk2.1 and Tbx5 [20],
expression of both Tbx4 and Tbx5 genes is not restricted
to lung tissue even though they are important in lungorganogenesis [7]. Interestingly, a dispersed group of Tbx4
gene enhancers are found to be responsible for the distinct
tissue locations of this gene [8]. Among these, a 5.5 kb
fragment of genomic sequences in Tbx4 intron 3 is related
to its expression in early embryonic lung. Our DNA se-
quence analysis suggests that several DNA fragments in
this region, particularly an approximately 500 bp fragment
Figure 6 Both myofibroblasts (SMA positive) and lipofibroblasts (ADRP positive) were marked by the Tbx4 lung enhancer driven
Tet-On system. E18.5 lung tissue sections of triple transgenic mice (Tbx4-rtTA/TetO-Cre/mT-mG) with different Dox induction during early or late
gestation as indicated were co-stained with mGFP/ADRP (A) or mGFP/SMA (B). Cell nuclei, counter-stained with DAPI (blue), were not included in
the merged panels. ADRP, adipophilin; DAPI, 4',6-diamidino-2-phenylindole; Dox, doxycycline; E, embryonic day; SMA, α-smooth muscle actin.
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species that develop lungs or lung-like gas exchange struc-
tures. This suggests that this DNA regulatory element
may be important for lung structure formation. However,
further experiments to examine individual fragments of
the mouse Tbx4 genomic region and compare their gene
regulatory activities among different specimens will be
needed to understand fully the role of mouse Tbx4 lung
enhancer in lung morphogenesis. Furthermore, whether
these conserved fragments of DNA sequences in each spe-
cies are involved in regulating Tbx4 gene expression also
needs to be experimentally analyzed.
We have used this lung-specific DNA enhancer of Tbx4
gene to generate a Tet-On inducible transgenic system in
mice. In combination with Cre-mediated reporter mice,we have clearly demonstrated that developing lung mesen-
chymal cells can be specifically marked from the beginning
of lung formation, which makes these cells distinguishable
from the mesenchymal cells arising from other organs. We
have shown for the first time that lung mesenchymal cells
can be targeted in an organ-specific manner by using the
Tbx4 lung enhancer, rather than the entire endogenous
Tbx4 promoter as in the Tbx4-Cre knockin model [7]. This
provides a powerful genetic tool with which to study the
functions of genes in lung mesenchymal development, and
to isolate and trace lung mesenchymal cell lineages during
prenatal development through postnatal development to
adulthood. More importantly, it provides the potential to
generate unique mouse models mimicking lung interstitial
diseases without adversely affecting other organs and
Figure 7 NG2-positive cells were targeted by the Tbx4-lung enhancer driven Tet-On system. Lung tissue sections of the triple transgenic
mice (Tbx4-rtTA/TetO-Cre/mT-mG) with different Dox induction as indicated were co-immunostained by GFP, NG2, and SMA or PECAM-1. (A) In
the E18.5 lung of the triple transgenic mice with Dox induction from E6.5 to E18.5, NG2-positive cells, including SMA-positive vasculature smooth
muscle cells and SMA-negative pericytes, were all marked by GFP expression, suggesting that these cells were targeted by the Tet-On system in
fetuses. (B-C) With Dox induction at either mid-gestation (E11.5 to E15.5) or late gestation (E15.5 to E18.5), most NG-2 positive cells of the triple
transgenic mouse lungs at E15.5 (B) or E18.5 (C) were positive for GFP. These NG2-positive cells were adjacent to PECAM-1 positive endothelial
cells. Dox, doxycycline; E, embryonic day; PECAM-1, platelet endothelial cell adhesion molecule; SMA, α-smooth muscle actin.
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lung enhancer is activated specifically in lung mesenchymal
cells are not yet completely clear, and also will need further
investigation. It is possible that specific lung mesenchymal
cells may express a unique array of transcription factors
that interact and activate the Tbx4 lung enhancer. In con-
trast, mesenchymal cells in other tissues may lack some ofthese specific transcriptional activators, resulting in sup-
pression of this particular Tbx4 gene regulatory element,
but not endogenous Tbx4 gene expression that can be acti-
vated by multiple regulatory elements. Furthermore, our
experiments also show that the Tbx4 lung enhancer is not
persistently active in all lung mesenchymal cells. Its activity
is turned off in some committed and/or differentiated
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particularly in pulmonary endothelial cells and vascular
smooth muscle cells. Whether active Tbx4 lung enhancer
activity is related to lung mesenchymal progenitor cells or
is associated with cell differentiation status remains to be
determined.
Another feature of our Tbx4-rtTA-mediated Tet-On Cre
inducible system is the combination of the Cre-mediated
reporter and LacZ reporter systems. Cre-mediated mGFP
expression is the marker for cells that had and/or have in-
duced Cre expression, while LacZ expression indicates ac-
tive Tbx4 lung enhancer activity at the time of examination.
Therefore, using this system, we have been able to deter-
mine the dynamic changes and fates of lung mesenchymal
cells with Tbx4 lung enhancer activity. In early lung buds,
the majority of these mesenchymal progenitors can be
marked using this Tbx4 lung enhancer, and these cells are
able to differentiate to endothelial cells and smooth muscle
cells of both airway and vasculature. However, the multi-
potent differentiation potential of these mesenchymal
progenitor cells is reduced during the course of lung devel-
opment, as the majority of endothelial cells and vascular
smooth muscle cells are neither labeled by Cre-mediated
mGFP expression if Dox induction is given after E11.5 and
E15.5, respectively, nor detected for LacZ expression. How-
ever, lung airway smooth muscle cells and subtypes of fi-
broblasts (lipofibroblast and myofibroblast) are positive
for induced mGFP expression even if Dox is given at
late gestation. Therefore, differential targeting of mouse
lung mesenchymal progenitors and related cell lineages
can be achieved by controlling the time windows of Dox
induction.
Interestingly, a proportion of mesenchymal cells in post-
natal developing and even adult lung are still active for the
Tbx4-lung enhancer. These cells are located adjacent to al-
veolar epithelial cells and alveolar endothelial cells of adult
lung alveolar structure, and are positive for NG2 or SMA
staining [see Additional file 2], suggesting that these may
be pericytes and myofibroblasts. Therefore, our Tbx4-lung
enhancer driven targeting driver line has the potential to
be used in the study of adult lung diseases, such as
asthma, emphysema and interstitial pulmonary fibrosis. It
could be used to create new disease models, to determine
the response of targeted cell lineages to specific injuries
and/or to test intervention approaches to prevent or at-
tenuate pathological processes. Moreover, understanding
developmental lung mesenchymal specificity is also im-
portant when considering the future design of cell-based
therapies. For example, the role of bone marrow-derived
mesenchymal stem cells in lung injury repair and regener-
ation is controversial, although their effects on modulating
immune and inflammatory responses are well recognized
[21]. This raises the question whether mesenchymal stem
cells derived from lung may function better in repairinglung structures than those originating from other organs
such as bone marrow [22]. Our newly generated Tet-On
system will make it possible to compare mesenchymal
stem cells of lung with those of non-lung origins in mice
by marking developing lung mesenchymal cells with pre-
natal Dox induction. Comparison of these two groups of
cells and characterization of their molecular signatures
under both physiological and pathological conditions will
greatly advance our knowledge about lung biology and
pulmonary diseases.
Conclusions
Although mesenchymal cells in developing lung display
complicated heterogeneous phenotypes, they are prob-
ably derived from splanchnic mesoderm surrounding
lung progenitors in foregut endoderm. We have found
an evolutionally conserved Tbx4 lung enhancer that is
active specifically in lung mesenchymal progenitors and
subsets of their derived cells. Therefore, with our newly
created Tbx4 lung enhancer-driven Tet-On inducible
system, lung mesenchymal cells can be specifically and
differentially targeted for the first time by controlling the
doxycycline induction time window. This novel system
provides a unique tool to study lung mesenchymal cell
lineages and gene functions in lung mesenchymal devel-
opment, injury repair, and regeneration in mice.
Methods
DNA vector construction
rtTA2s-M2 DNA fragment was amplified from pTet-On Ad-
vanced vector (Clontech, Mountain View, CA, USA) using
primers5′-CGGCCCCGAATTCACCATGTCTAGA-3′ and
5′-ACGCGTCGACACTTAGTTACCCGGGGAGCATG-3′,
and subcloned to EcoRI/SalI digested pBluescript KS II to
generate pBS-rtTA. A 5.5 kb DNA fragment of mouse
Tbx4 lung enhancer and a 0.9 kb DNA fragment of
HSP68 minimal promoter were obtained by NotI and
SmaI/SfoI digestion of pDBM3 [8], respectively, and sub-
cloned into pBS-rtTA to generate pBS-Tbx4-rtTA. Finally,
IRES-T-LacZ DNA fragment was obtained by digesting
pNTR-lacZ-PGKNeolox plasmid provided by Dr. Vesa
Kaartinen at University of Michigan, and inserted to pBS-
Tbx4-rtTA to produce an intact transgenic vector pBS-
Tbx4-rtTA-LacZ. The prokaryotic part of the vector was
then removed by NotI digestion and the 12 kb transgenic
DNA fragment was isolated for C57BL/6 pronuclear injection.
Mouse strains, breeding, and genotyping
Tbx4-rtTA mouse line was generated at the University of
California at Los Angeles (UCLA) Transgenic Core facil-
ity. The founders were identified by genomic DNA PCR
using primers 5′-GGA AGG CGA GTC ATG GCA AGA-
3′ and 5′-AGG TCA AAG TCG TCA AGG GCA T-3′.
The transgenic mice were further verified by DNA
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SalI. DIG-labeled nonradioactive detecting system (Roche,
Indianapolis, IN, USA) was used.
The TetO-Cre mouse line was originally provided by Dr.
Jeffrey Whitsett at Cincinnati Children’s Hospital [23,24].
mT-mG double fluorescent Cre reporter mice were ob-
tained from Jackson Laboratory (Bar Harbor, ME, USA)
[14]. All mice were bred in C57BL/6 background. Fetal lung
mesenchymal-specific Cre expression was induced by Dox
administration from different gestational stages by feeding
the pregnant mice with both Dox food (625 mg/kg; Test-
Diet, Richmond, IN, USA) and Dox water (0.5 mg/ml;
Sigma, St. Louis, MO, USA). In postnatal pups, Cre induc-
tion was initiated by a single intraperitoneal injection of
Dox (100 mg/kg body weight) followed by Dox oral admin-
istration, the same as described above for the entire induc-
tion period. All reported mouse studies were approved by
the Institutional Animal Care and Use Committee at the
Saban Research Institute of Children’s Hospital Los Angeles.
Fluorescence protein and immunofluorescence detection
Mouse embryos or lung tissues were dissected. For mT
and mG detection, mouse embryos or tissues were directly
imaged under a Leica MZFLIII fluorescence dissecting
microscope. The embryos or tissues were then fixed with
4% buffered paraformaldehyde and embedded either in op-
timal cutting temperature (OCT) compound for frozen
section or in paraffin for regular histological section. Tissue
frozen sections were washed in PBS, and mounted with
VECTASHIELD medium with DAPI (Vector Laboratories,
Burlingame, CA, USA). Immunofluorescence staining was
performed following methods published previously [25].
The related antibodies were: rabbit anti-GFP (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), goat anti-GFP
(Abcam, Cambridge, MA, USA), mouse anti-cytokeratin
and mouse anti-SMA (Sigma), rabbit anti-PECAM-1
(LSBio, Seattle, WA, USA), rabbit anti-lacZ (MP Biomedi-
cals, Solon, OH, USA), mouse anti-ADRP (BioGenex,
Fremont, CA, USA), rabbit anti-NG2 chondroitin sulfate
proteoglycan (Millipore, Billerica, MA, USA), hamster
anti-T1α (DSHB at the University of Iowa) and mouse
anti-CGRP (Sigma). Fluorescent signals were detected
using a Zeiss LSM710 confocal microscope at the Imaging
Core Facility of the Saban Research Institute of Children’s
Hospital Los Angeles. All experiments were repeated at
least five times and data represent consistent results.X-gal staining
Lung specimens were briefly fixed with 4% paraformal-
dehyde in PBS containing 2 mM MgCl2 and embedded
in OCT. Lung frozen sections were incubated with X-gal
reaction buffer following the procedures described in a
previous publication [17].Additional files
Additional file 1: Lung neuroendocrine cells were not targeted by
the Tbx4 lung enhancer, shown by co-immunostaining of GFP
(green) and CGRP (red) for E18.5 lung tissue section of the triple
transgenic mouse (Tbx4-rtTA/TetO-Cre/mT-mG) with Dox induction
from E6.5 to E18.5. Blue: DAPI nuclear counterstaining.
Additional file 2: Cells with Tbx4 lung enhancer activity in adult
lungs. (A) Adult mice with triple transgenic genotypes (Tbx4-rtTA/TetO-Cre/
mT-mG) were induced by Dox administration for two weeks. The lung tissue
sections were co-immunostained with GFP and one of the cell markers as
indicated. Cells with GFP expression (green) were not positive for T1α and
PECAM-1 (red). However, most GFP-positive cells were positive for NG2, and a
few GFP-positive cells were positive for SMA, shown by overlapped co-
staining (yellow color). DAPI was used for nuclear counterstaining (blue). (B)
Evaluation of adult transgenic reporter mouse lungs in the absence of Dox
induction. Mouse genotypes are indicated above the panel. Expression of
endogenous mTomato (red) and mGFP (green) was examined for the lung
frozen sections under fluorescence microscope. DAPI was used for nuclear
counterstaining (blue).
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